New Key Statistics Module, Z-Score and F-Score
SZSE:002332 Key Ratios
Market Cap ¥ M | 11,722.08 |
Enterprise Value ¥ M | 10,299.55 |
P/E(ttm) | 20.08 |
PE Ratio without NRI | 19.43 |
Forward PE Ratio | 17.17 |
Price/Book | 1.98 |
Price/Sales | 2.73 |
Price/Free Cash Flow | 30.52 |
Price/Owner Earnings | 31.35 |
Payout Ratio % | 0.49 |
Revenue (TTM) ¥ M | 4,204.00 |
EPS (TTM) ¥ | 0.59 |
Beneish M-Score | -2.43 |
10-y EBITDA Growth Rate % | 16.90 |
5-y EBITDA Growth Rate % | 6.50 |
y-y EBITDA Growth Rate % | -22.40 |
EV-to-EBIT | 15.30 |
EV-to-EBITDA | 15.30 |
PEG | 2.99 |
Shares Outstanding M | 989.20 |
Net Margin (%) | 13.82 |
Operating Margin % | 15.70 |
Pre-tax Margin (%) | 15.94 |
Quick Ratio | 2.36 |
Current Ratio | 3.14 |
ROA % (ttm) | 8.30 |
ROE % (ttm) | 10.20 |
ROIC % (ttm) | 13.04 |
Dividend Yield % | 2.52 |
Altman Z-Score | 7.71 |
SZSE:002332 Number of Guru Trades
SZSE:002332 Volume of Guru Trades
Gurus Latest Trades with SZSE:002332
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002332 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zhejiang Xianju Pharmaceutical Co Ltd Insider Transactions
No Available Data